H. Heijerman (The Hague, The Netherlands), M. Ballmann (Hannover, Germany)
Serial measurements of lung function in cystic fibrosis patients during the first years of life
M. Gappa, A. Bahr, A. F. Hoo, S. Junge, M. Ballmann (Hannover, Germany; London, United Kingdom)
|  |
Low reliability of RINT in slight symptomatic cystic fibrosis patients
V. Lucidi, A. Turchetta, S. Bella, T. Salerno, L. Massenzi, F. D'Orio, M. Castro (Rome, Italy)
| |
Impulse oscillometry in patients with cystic fibrosis: relationship to dynamic lung volumes
A. H. Kendrick, L. Crocker, N. Jarad (Bristol, United Kingdom)
| |
Sustained maximum inspiratory pressure in patients with cystic fibrosis and severe airway obstruction
L. Menin, A. Borruso, M. Carli, S. Ilic, B. M. Assael, C. Braggion (Verona, Italy)
| |
Increased IL-8 in exhaled breath condensate in cystic fibrosis during acute exacerbation
B. Balint, S. A. Kharitonov, I. Kazuhiro, P. Shah, D. Geddes, M. E. Hodson, P. J. Barnes (London, United Kingdom)
| |
Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis
G. Huels, P. Bittner-Dersch, D. Schüler, H. Lindemann (Giessen, Germany)
| |
Comparison of rhDNase delivery to children using dosimetric versus conventional nebulizers
S. G. Devadason, T. T. Huang, S. L. Walker, P. N. Le Souef (Perth, Australia)
| |
Loss of structural integrity and function of surfactant protein D (SP-D) by cystic fibrosis- related proteases
M. Griese, C. von Bredow, A. Wiesener, F. Lottspeich (Munich, Germany)
| |
ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease
C. I. U. Chen, I. Kleinau, A. Jung, N. Reinhardt, G. Doering, U. Wahn, K. P. Paul (Berlin, Tuebingen, Germany)
| |
A 2-year follow-up of exhaled nitric oxide (FeNO) and pulmonary function tests in young patients with cystic fibrosis
H. Grasemann, A. A. Colin (Essen, Germany; Boston, United States Of America)
| |
Compliance with treatment in UK children with cystic fibrosis
J. S. A. Lucas, H. K. Buckley, J. Abay, G. J. Connett (Southampton, United Kingdom)
| |
The influence of dornase alfa on long-term lung function in cystic fibrosis
J. W. Wilson, M. Lenkic, T. Kotsimbos, M. Bailey (Prahran, Australia)
| |
Methotrexat in the treatment of severely ill patients with cystic fibrosis
M. Ballmann, S. Junge, J. Freihorst, H. V. D. Hardt (Hannover, Germany)
| |
Treatment of Burholderia cepacia infection in patients with cystic fibrosis
W. H. Nikolaizik, F. Ratjen (Essen, Germany)
| |
Efficacy of two different vaccination schemes for influenza annual vaccination in cystic fibrosis patients 3-8-years-old
S. E. Doudounakis, P. Velentzas, D. Sofianos, G. Kikis, M. Theodoridou, G. Adam (Athens, Greece)
| |
Indication of pneumococcal vaccination in CF patients
A. Malfroot, I. De Schutter, F. Mascart, A. Crusiaux, I. Dab (Brussels, Belgium)
| |
Diagnosis of osteoporosis in adult CF patients: the need for careful evaluation
M. Heilmann, C. Lehmann, J. Hohlfeld, E. Leifke, G. Brabant, H. Fabel (Hannover, Germany)
| |
Changes in bone mineral density of lumbar spine during one year in patients with cystic fibrosis
A. Delmarco, S. Ilic, M. Rossini, S. Adami, G. Amenta, C. Braggion, B. M. Assael (Verona, Italy)
| |